Richard W. Mott, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 15,957 shares at $26.00 ($415K) on 2023-04-04, disclosed to the SEC on 2023-04-05.
Open-market sale of $415k TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.00 | 201 | $5K | 1.3% |
| 2 | $26.00 | 15,756 | $410K | 98.7% |
| Total | $26.00 avg | 15,957 | $415K | 100% |
| Filing → |
| TMCI | BUY | 2024-05-13 | $1.1M | — | Filing → |
| TMCI | SELL | 2023-04-10 | $105K | — | Filing → |
| TMCI | SELL | 2023-03-31 | $3.4M | — | Filing → |